ERBB2 and breast cancer: The distributions of hormone receptor status (ER, PR and HER-2) and molecular subtypes (triple-negative, Her-2 overexpression and luminal) of patients with BC presenting different SNP genotypes are shown in Supplementary Tables 4 and 5, respectively.